Healthier Capital Leads $16M Funding Round for Photon to Revolutionize Prescription Experience

Photon, a healthcare startup focused on modernizing the prescription experience, has secured a $16 million Series A funding round led by Healthier Capital. The funding aims to further Photon's mission to transform the prescription process, providing patients with real-time transparency and empowering them to make informed choices.

By integrating at the point of prescribing, Photon allows patients to select a pharmacy, view pricing and inventory information, and make decisions based on convenience and coverage before the prescription is sent. The platform uses artificial intelligence to process complex data across pharmacy networks, benefit structures, and formularies in real time, ultimately reducing abandoned prescriptions and improving the overall healthcare experience.

Founded in 2021, Photon has already helped millions of patients make better pharmacy decisions and is now poised to expand its marketplace integrations and health system partnerships. The company's long-term goal is to alleviate systemic burdens across the healthcare system by leveraging AI to identify and address structural issues. Healthier Capital, the lead investor, aims to support transformative healthcare innovators, partnering with companies like Photon to drive significant value creation and healthier outcomes for all.